{"disease":{"id":"diffuse-large-b-cell-lymphoma-dlbcl-abc-subtype","name":"diffuse large b cell lymphoma dlbcl abc subtype"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT02580552","title":"Safety, Tolerability and Pharmacokinetics of MRG-106 in Patients With Mycosis Fungoides (MF), CLL, DLBCL or ATLL","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":66,"lead_sponsor_name":"miRagen Therapeutics, Inc.","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}